Financial statements Noblepharma Bis

Balance sheet of Noblepharma Bis

Company age:
Age:
6 y. 11 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of NOBLEPHARMA BIS

Year
2021
2022
Total assets 102 200,79 2 336 846,72
A. Fixed assets 78 861,79 78 861,79
B. Current assets 23 339,00 2 257 984,93
C. Share capital contributions (basic funds) - -
D. Own shares (stocks) - -
Total liabilities 102 200,79 2 336 846,72
A. Equity 1 321,84 99 849,12
B. Liabilities and provisions for liabilities 100 878,95 2 236 997,60
I. Long-term liabilities - 1 942 095,12
II. Short-term liabilities - 294 902,48
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.